Kazia Enters Clinical Collaboration With Dana-farber Cancer In...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SYDNEY, Sept. 22, 2020 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with Dana-Farber Cancer Institute (DFCI) in the United States, to investigat...
Authors: LATEST ASIANET NEWS RELEASES
